(PharmaNewsWire.Com, May 31, 2017 ) According to Publisher, the Global Plasma Fractionation Market is accounted for $16.87 billion in 2015 and is expected to reach $28.03 billion by 2022 growing at a CAGR of 7.5% during the forecast period. Factors such as rising geriatric population and increasing number of hemophilic patients are boosting the market growth. However, strict government rules, huge cost and limited reimbursements are some of the factors hampering the market. Rising digit of Hemophilic Patients is creating growth opportunities for vendors in the market.
By product, immunoglobulin segment dominated the global market with largest share in 2013 owing to growing geriatric population with neurological and autoimmune disease. By region, North America accounted for largest market share followed by Europe. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to increasing digit of hemophilic patients and rising awareness of technologically advanced products in this region.
Some of the key players in Plasma Fractionation market include Octapharma AG, Chinese Biological Products, Inc., Baxter International, Inc., Bio Products Laboratory, Grifols International SA, Shanghai Raas Blood Products Co., Ltd, Csl, Ltd., China Biologic Products, Inc., Kedrion S.P.A., Biotest, Sanquin and LFB SA.
Applications Covered: - Rheumatology - Immunology - Haemato-oncology - Critical Care - Neurology - Pulmonology - Haematology - Other Applications
End Users Covered: - Academic Institutes - Hospitals and Clinics - Clinical Research Laboratories
Products Covered: - Protease Inhibitors - Coagulation Factor Concentrates o Prothrombin Complex Concentrates o Factor IX o Von Willebrand Factor (VWF) o Factor VIII o Fibrinogen Concentrates o Factor XIII - Fractionation Process - Albumin - Immunoglobulin o Subcutaneous Immunoglobulin o Intravenous Immunoglobulin o Other Immunoglobulins - Other Plasma Products
Regions Covered: - North America o US o Canada o Mexico - Europe o Germany o France o Italy o UK o Spain o Rest of Europe - Asia Pacific o Japan o China o India o Australia o New Zealand o Rest of Asia Pacific - Rest of the World o Middle East o Brazil o Argentina o South Africa o Egypt
What our report offers: - Market share assessments for the regional and country level segments - Market share analysis of the top industry players - Strategic recommendations for the new entrants - Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets - Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations) - Strategic recommendations in key business segments based on the market estimations - Competitive landscaping mapping the key common trends - Company profiling with detailed strategies, financials, and recent developments - Supply chain trends mapping the latest technological advancements
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
